Wei, Yanyu http://orcid.org/0000-0002-5127-0321
Lu, Wei
Yu, Yehua
Zhai, Yuanmei
Guo, Hezhou
Yang, Shaoxin
Zhao, Chong
Zhang, Yanjie
Liu, Jiali
Liu, Yuhui http://orcid.org/0000-0002-5952-8948
Fei, Jian http://orcid.org/0000-0001-7755-0818
Shi, Jun http://orcid.org/0000-0003-0780-5242
Funding for this research was provided by:
National Natural Science Foundation of China (81870132, 81261120568)
Science and Technology Commission of Shanghai Municipality (18DZ2290700)
Article History
Received: 30 September 2020
Revised: 11 March 2021
Accepted: 29 March 2021
First Online: 22 April 2021
Compliance with ethical standards
:
: The authors declare no competing interests.
: All human bone marrow specimens were collected from patients diagnosed with AML at the Shanghai Ninth People’s Hospital, China, from 2016 to 2020. Informed consent was obtained from all patients and the project was approved by the Ethics Committee of Shanghai Ninth People’s Hospital. Six- to eight-week-old C57BL/6 or miR-29c&b2 knockout C57BL/6 mice were purchased from the Shanghai Model Organisms Center, Inc (Shanghai, China). Six- to eight-week-old NOD-SCID mice were purchased from Shanghai SLAC Laboratory Animal Co., Ltd (Shanghai, China). All experiments with mice were performed strictly in accordance with a protocol approved by the Administrative Panel on Laboratory Animal Care of the Shanghai Ninth People’s Hospital.